Cencora Raises Fiscal 2026 Adjusted Diluted EPS Outlook to at Least $17.90
Bitget2026/10/21 11:33- Cencora now expects fiscal 2026 adjusted diluted EPS of at least $17.90, versus its previous $17.75-$17.95 range.
- The revised outlook reflects strength in its U.S. Healthcare Solutions segment.
- Its planned American Oncology Network acquisition carries a $2.4 billion enterprise value, including up to $100 million in contingent value rights.
- The acquisition is expected to lift adjusted diluted EPS in the second year following closing.
- Fiscal 2027 expectations will be discussed on the fiscal fourth-quarter 2026 earnings call on November 4, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jim Cramer Calls Ralph Lauren Stock Top Apparel Pick Before Thursday Earnings
Yardeni Says Analysts Still See S&P 500 Earnings Near $500 Per Share by 2028
US stock contracts related to AI cloud computing infrastructure collectively fell over the past 24 hours
Northland: The transaction between Mawell Technology and Lumentum highlights the scarce value of InP devices, benefiting related U.S. concept stocks
Northland Capital Markets has upgraded the ratings of Coherent and Applied Optoelectronics following MaxLinear's acquisition of Lumentum.
Crypto prices
More
